In the last trading session, 3.01 million Pliant Therapeutics Inc (NASDAQ:PLRX) shares changed hands as the company’s beta touched 1.34. With the company’s per share price at $1.37 changed hands at $0.02 or 1.48% during last session, the market valuation stood at $84.10M. PLRX’s last price was a discount, traded about -1075.18% off its 52-week high of $16.10. The share price had its 52-week low at $1.10, which suggests the last value was 19.71% up since then.
Analysts gave the Pliant Therapeutics Inc (PLRX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.69. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended PLRX as a Hold, 5 felt it is a Buy and 0 rated the stock as Underweight.
Pliant Therapeutics Inc (NASDAQ:PLRX) trade information
Instantly PLRX was in green as seen at the end of in last trading. With action -0.72%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -89.60%, with the 5-day performance at -0.72% in the red. However, in the 30-day time frame, Pliant Therapeutics Inc (NASDAQ:PLRX) is -7.43% down.
The consensus price target for the stock as assigned by Wall Street analysts is 2.5, meaning bulls need an upside of 45.2% from its current market value. According to analyst projections, PLRX’s forecast low is 2 with 3 as the target high. To hit the forecast high, the stock’s price needs a -118.98% plunge from its current level, while the stock would need to soar -45.99% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -78.30%. The 2025 estimates are for Pliant Therapeutics Inc earnings to increase by 23.34%, but the outlook for the next 5-year period is at 21.07% per year.
PLRX Dividends
Pliant Therapeutics Inc is expected to release its next quarterly earnings report in June.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 8.2335% or 4.97 million shares worth $53.45 million as of 2024-06-30.
